XML 56 R45.htm IDEA: XBRL DOCUMENT v3.25.2
Investment Portfolio - Schedule of Composition by Industry Sector (Details) - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2025
Dec. 31, 2024
Schedule of Investments [Line Items]    
Fair Value $ 1,608,953 [1],[2] $ 1,064,073 [3]
Percentage of Portfolio | Industry Concentration Risk    
Schedule of Investments [Line Items]    
Percentage of Portfolio 100.00% 100.00%
Banks    
Schedule of Investments [Line Items]    
Fair Value $ 706 $ 1,148
Banks | Percentage of Portfolio | Industry Concentration Risk    
Schedule of Investments [Line Items]    
Percentage of Portfolio 0.00% 0.10%
Capital Goods    
Schedule of Investments [Line Items]    
Fair Value $ 232,901 $ 160,388
Capital Goods | Percentage of Portfolio | Industry Concentration Risk    
Schedule of Investments [Line Items]    
Percentage of Portfolio 14.50% 15.10%
Commercial & Professional Services    
Schedule of Investments [Line Items]    
Fair Value $ 257,562 $ 207,960
Commercial & Professional Services | Percentage of Portfolio | Industry Concentration Risk    
Schedule of Investments [Line Items]    
Percentage of Portfolio 16.00% 19.60%
Consumer Discretionary Distribution & Retail    
Schedule of Investments [Line Items]    
Fair Value $ 8,629 $ 6,683
Consumer Discretionary Distribution & Retail | Percentage of Portfolio | Industry Concentration Risk    
Schedule of Investments [Line Items]    
Percentage of Portfolio 0.50% 0.60%
Consumer Durables & Apparel    
Schedule of Investments [Line Items]    
Fair Value $ 21,942 $ 9,409
Consumer Durables & Apparel | Percentage of Portfolio | Industry Concentration Risk    
Schedule of Investments [Line Items]    
Percentage of Portfolio 1.40% 0.90%
Consumer Services    
Schedule of Investments [Line Items]    
Fair Value $ 95,635 $ 59,984
Consumer Services | Percentage of Portfolio | Industry Concentration Risk    
Schedule of Investments [Line Items]    
Percentage of Portfolio 5.90% 5.60%
Consumer Staples Distribution & Retail    
Schedule of Investments [Line Items]    
Fair Value $ 15,963 $ 16,427
Consumer Staples Distribution & Retail | Percentage of Portfolio | Industry Concentration Risk    
Schedule of Investments [Line Items]    
Percentage of Portfolio 1.00% 1.60%
Equity Real Estate Investment Trusts (REITs)    
Schedule of Investments [Line Items]    
Fair Value $ 21,221 $ 20,676
Equity Real Estate Investment Trusts (REITs) | Percentage of Portfolio | Industry Concentration Risk    
Schedule of Investments [Line Items]    
Percentage of Portfolio 1.30% 1.90%
Financial Services    
Schedule of Investments [Line Items]    
Fair Value $ 146,264 $ 96,682
Financial Services | Percentage of Portfolio | Industry Concentration Risk    
Schedule of Investments [Line Items]    
Percentage of Portfolio 9.10% 9.10%
Food, Beverage & Tobacco    
Schedule of Investments [Line Items]    
Fair Value $ 19,964 $ 0
Food, Beverage & Tobacco | Percentage of Portfolio | Industry Concentration Risk    
Schedule of Investments [Line Items]    
Percentage of Portfolio 1.20% 0.00%
Health Care Equipment & Services    
Schedule of Investments [Line Items]    
Fair Value $ 210,271 $ 157,954
Health Care Equipment & Services | Percentage of Portfolio | Industry Concentration Risk    
Schedule of Investments [Line Items]    
Percentage of Portfolio 13.10% 14.90%
Insurance    
Schedule of Investments [Line Items]    
Fair Value $ 97,746 $ 92,396
Insurance | Percentage of Portfolio | Industry Concentration Risk    
Schedule of Investments [Line Items]    
Percentage of Portfolio 6.10% 8.70%
Materials    
Schedule of Investments [Line Items]    
Fair Value $ 35,900 $ 21,447
Materials | Percentage of Portfolio | Industry Concentration Risk    
Schedule of Investments [Line Items]    
Percentage of Portfolio 2.20% 2.00%
Media & Entertainment    
Schedule of Investments [Line Items]    
Fair Value $ 7,310 $ 0
Media & Entertainment | Percentage of Portfolio | Industry Concentration Risk    
Schedule of Investments [Line Items]    
Percentage of Portfolio 0.50% 0.00%
Pharmaceuticals, Biotechnology & Life Sciences    
Schedule of Investments [Line Items]    
Fair Value $ 44,249 $ 34,250
Pharmaceuticals, Biotechnology & Life Sciences | Percentage of Portfolio | Industry Concentration Risk    
Schedule of Investments [Line Items]    
Percentage of Portfolio 2.80% 3.20%
Real Estate Management & Development    
Schedule of Investments [Line Items]    
Fair Value $ 89,981 $ 43,784
Real Estate Management & Development | Percentage of Portfolio | Industry Concentration Risk    
Schedule of Investments [Line Items]    
Percentage of Portfolio 5.60% 4.10%
Software & Services    
Schedule of Investments [Line Items]    
Fair Value $ 214,721 $ 78,631
Software & Services | Percentage of Portfolio | Industry Concentration Risk    
Schedule of Investments [Line Items]    
Percentage of Portfolio 13.40% 7.40%
Technology Hardware & Equipment    
Schedule of Investments [Line Items]    
Fair Value $ 264 $ 264
Technology Hardware & Equipment | Percentage of Portfolio | Industry Concentration Risk    
Schedule of Investments [Line Items]    
Percentage of Portfolio 0.00% 0.00%
Telecommunication Services    
Schedule of Investments [Line Items]    
Fair Value $ 11,533 $ 0
Telecommunication Services | Percentage of Portfolio | Industry Concentration Risk    
Schedule of Investments [Line Items]    
Percentage of Portfolio 0.70% 0.00%
Transportation    
Schedule of Investments [Line Items]    
Fair Value $ 74,733 $ 54,412
Transportation | Percentage of Portfolio | Industry Concentration Risk    
Schedule of Investments [Line Items]    
Percentage of Portfolio 4.60% 5.10%
Utilities    
Schedule of Investments [Line Items]    
Fair Value $ 1,458 $ 1,578
Utilities | Percentage of Portfolio | Industry Concentration Risk    
Schedule of Investments [Line Items]    
Percentage of Portfolio 0.10% 0.10%
[1] See Note 8 for additional information regarding the fair value of the Company’s financial instruments.
[2] Security may be an obligation of one or more entities affiliated with the named company.
[3] See Note 8 for additional information regarding the fair value of the Company’s financial instruments.